source https://www.pharmatutor.org/pharma-news/2020/glenmark-receives-approval-for-oral-antiviral-favipiravir-for-the-treatment-of-mild-to-moderate-covid-19
Subscribe to:
Post Comments (Atom)
-
National Institute for Research in Reproductive Health (NIRRH), formerly known as Institute for Research in Reproduction is a premier res...
-
Results from a clinical trial published in 2011 confirmed the benefit of using Avastin over laser therapy for treating the most severe c...
-
Vacancy for Ph.D in life sciences at Indian Institute of Technology admin Wed, 01/20/2021 - 16:59 source https://www.pharmatutor.org/con...
No comments:
Post a Comment